Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 12, Issue 5-6, 2009, Pages 362-388

  Neafsey, Pat ^a   Ginsberg, Gary ^b   Hattis, Dale ^c   Johns, Douglas O ^d   Guyton, Kathryn Z ^d   Sonawane, Babasaheb ^d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Mail Stop 11CHA ^*  (United States)

^c CLARK UNIVERSITY   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; BENZENE; BROMOBENZENE; CARBON TETRACHLORIDE; CHLORZOXAZONE; CYTOCHROME P450 2E1; CYTOCHROME P450 INHIBITOR; DIMETHYLNITROSAMINE; ENFLURANE; HALOTHANE; NITROSAMINE; PARACETAMOL; VINYLIDENE CHLORIDE; XENOBIOTIC AGENT;

ALCOHOLISM; BREAST CANCER; COLORECTAL CANCER; DRUG DEPENDENCE; DRUG INHIBITION; DRUG METABOLISM; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ESOPHAGUS CANCER; ETHNICITY; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LIVER CIRRHOSIS; LIVER TOXICITY; LUNG CANCER; NASOPHARYNX CANCER; NONHUMAN; PHENOTYPE; POPULATION DISTRIBUTION; REVIEW; RISK ASSESSMENT; STOMACH CANCER; TOXICOKINETICS; UTERINE CERVIX CARCINOMA;

ANIMALS; CYTOCHROME P-450 CYP2E1; ENZYME INDUCTION; ENZYME INHIBITORS; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; MODELS, BIOLOGICAL; PHENOTYPE; POLYMORPHISM, GENETIC; XENOBIOTICS;

EID: 75749113367     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937400903158359     Document Type: Review

References (190)

1. Agundez, J., Rodriguez, I., Olivera, M., Ladero, J., Garcia, M., Ribera, J., and Benitez, J. 1997. CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians. Age Ageing 26:147-151.
2. Albano, E., Tomasi, A., Goria-Gatti, L., Persson, O., Tereius, Y., Goria-Gatti, L., Ingelman-Sundberg, M., and Dianzani, M. 1991. Role of ethanol-inducible cytochrome P450 (P450IIEI) in catalyzing the free radical activation of aliphatic alcohols. Biochem. Pharmacol. 41:1895-1902.
3. Antonarakis, S. E. 1998. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group 11:1-3.
4. Anwar, W., Abdel-Rahman, S., El-Zein, R., Mostafa, H., and Au, W. 1996. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17:1923-1929.
5. Barcelo, S., Gardiner, J., Gescher, A., and Chipman, J. 1996. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforphane. Carcinogenesis (Lond.) 17:277-282.
6. Block, G., Patterson, B., and Subar, A. 1992. Fruit, vegetables and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer 18:1-29.
7. Boccia, S., DeLauretis, A., Gianfagna, F., van Duijn, C. M., and Ricciardi, G. 2007. CYP2E1 PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature. Carcinogenesis 28:101-106.
8. Bolt, H. M., Roos, P. H., and Thier, R. 2003. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: Consequences for occupational and environmental medicine. Int. Arch. Occup. Environ. Health 76:174-185.
9. Borowsky, S., and Lieber, C. 1978. Interaction of methadone and ethanol metabolism. J. Pharmacol. Exp. Ther. 207:123-129.
10. Brady, J., Ishizaki, H., Fukuto, J., Lin, M., Fadel, A., Gupac, J., and Yang, C. 1991. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem. Res.Toxicol. 4:642-647.
11. Brockmoller, J., Cascorbi, I., Kerb, R., and Roots, I. 1996. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 56:3915-3925.
12. Carriere, V., Goasduff, T., Ratanasavanh, D., Morel, F., Gautier, J. C., Guillouzo, A., Beaune, P., and Berthou, F. 1993. Both cytochrome P450 2E1 and 1A1 are involved in the metabolism of chlorzaxazone. Chem. Res. Toxicol. 6:852-857.
13. Carriere V., Berthou, F., Baird, S., Belloc, C., Beaune, P., and de Waziers, I. 1996. Human cytochrome P450 2E1: From genotype to phenotype. Pharmacogenetics 6:203-211. (Pubitemid 26226312)
14. Carroccio, A., Wu, D., and Cederbaum, AI. 1994. Ethanol increases content and activity of human cytochrome P4502E1 in a transduced HepG2 cell line. Biochem. Biophys. Res. Commun. 203:727-733.
15. Cartmell, M. T., Schulz, H. U., O'Reilly, D. A., Yang, B. M., Kielstein, V., Dunlop, S. P., Halangk, W., Demaine, A. G., and Kingsnorth, A. N. 2005. Cytochrome P450 2E1 high activity polymorphism in alcohol abuse and end-organ disease. World J. Gastroenterol. 11:6445-6449.
16. Chao, Y., Young, T., Chang, W., Tang, H., and Hsu, C. 1995. An investigation of whether polymorphisms of cytochrome P4502E1 are genetic markers of susceptibility to alcoholic end-stage organ damage in a Chinese population. Hepatology 22:1409-1414.
17. Cho, E. Y., Yun, C. H., Chae, H. Z., Chae, H. J., and Ahn, T. 2008a. Anionic phospholipids-induced regulation of reactive oxygen species production by human cytochrome P450 2E1. FEBS Lett. 582:1771-1776.
18. Cho, E. Y., Yun, C. H., Chae, H. Z., Chae, H. J., and Ahn, T. 2008b. Lysophophatidylserine-induced functional switch of human cytochrome P450 1A2 and 2E1 from monooxygenase to phospholipase D. Biochem. Biophys. Res. Commun. 376:584-589.
19. Cho, U. S., Park, E. Y., Dong, M. S., Park, B. S., Kim, K., and Kim, K. H. 2003. Tight-binding inhibition by alpha-naphthaoflavone of cytochrome P450 1A2. Biochim. Biophys. Acta 1648:195-202. (Pubitemid 38234621)
20. Chen, K., Day, N., Duffy, S., Lam, T., Fok, M., and Wong, J. 1992. Pickled vegetables in the etiology of esophageal cancer in Hong Kong Chinese. Lancet 339:1314-1318.
21. Degawa, M., Stern, S., Martin, M., Guengerich, F., Fu, P., Ilett, K., Kaderlik, R., and Kadlubar, F. 1994. Metabolic activation and carcinogen DNA adduct detection in human larynx. Cancer Res. 54:4915-4919. (Pubitemid 24289421)
22. den Dunnen, J. T., and Antonarakis, S. E. 2001. Nomenclature for the description of human sequence variations. Hum. Genet. 109:121-124.
23. Diehl, A. M., Bisgaard, H. C., Kren, B. T., and Steer, C. J. 1991. Ethanol interferes with regeneration-associated changes in biotransforming enzymes: A potential mechanism underlying ethanol's carcinogenicity? Hepatology 13:722-727.
24. Dong, Z., Hong, J., Ma, Q., Li, DC., Bullock, J., Gonzalez, F. J., Park, S. S., Gelboin, H. V., and Yang, C. S. 1988. Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Arch. Biochem. Biophys. 263:29-35.
25. d'Errico, A., Malats, N., Vineis, P., and Boffetta, P. 1999. Review of studies of selected metabolic polymorphisms and cancer. In Metabolic polymorphisms and susceptibility to cancer, eds. P. Vineis, N. Malats, M. Lang, A. d'Errico, N. Caporaso, J. Cuzick, and P. Boffetta, pp. 323-345. Lyon: International Agency for Research on Cancer (IARC), Scientific Publication No. 148.
26. Eap, C. B., Schnyder, C., Besson, J., Savary, L., and Buclin, T. 1998. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers. Clin. Pharmacol. Ther. 64:52-57.
27. Eliasson, E., Johansson, I., and Ingelman-Sundberg, M. 1988. Ligand dependent maintenance of ethanol inducible cytochrome P-450 in primary rat hepatocyte cell cultures. Biochem. Biophys. Res. Commun. 150:436-443.
28. Ernstgard, LW., Warholm, M., and Johanson, G. 2004. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity. Br. J. Clin. Pharmacol. 58:190-200.
29. Fairbrother, K., Grove, J., Waziers, I., Steimel, D., Day, C., Crespi, C., and Daly, A. 1998. Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8:543-552.
30. Farker, K., Lehmann, M., Kastner, R., Hoffman, A., Janitzky, V., Schubert, J., Matz, U., and Hofmann, W. 1998. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations. Int. J. Clin. Pharmacol. Ther. 36:463-468.
31. Fritsche, E., Pittman, G. S., and Bell, D. A. 2000. Localization, sequence analysis and ethnic distribution of a 96 bp insertion in the promoter of the human CYP2E1 gene. Mutat. Res. Genom. 432:1-5.
32. Gannett, P., Iversen, P., and Lawson, T. 1990. The mechanism of inhibition of cytochrome P-450IIE1 by dihydrocapsaicin. Bioorg. Chem. 18:185-198.
33. George, J., Byth, K., and Farrell, G. 1995. Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem. Pharmacol. 50:727-730.
34. Ginsberg, G., Smolenski, S., Hattis, D., and Sonawane, B. 2002. Population distribution of aldehyde dehydrogenase-2 genetic polymorphism: Implications for risk assessment. Regul. Toxicol. Pharmacol. 36:297-309.
35. Girre, C., Lucas, D., Hispard, E., Menez, C., Dally, S., and Menez, J. 1994. Assessment of cytochrome P450 2E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem. Pharmacol. 47:1503-1508.
36. Guengerich, F., and Turvy, C. 1991. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256:1189-1194.
37. Guengerich, F., Kim, D., and Iwasaki, M. 1991. Role of human cytochrome P-450IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:168-179.
38. Gut, I., Nedelcheva, V., Soucek, P., Stopka, P., and Tichavska, B. 1996. Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ. Health Perspect. 104:1211-1218.
39. Hanoika, N., Tanaka-Kagawa, T., Miyata, Y., Makino, Y., Ohno, A., Yoda, R., Jinno, H., and Ando, M. 2003. Functional characterization of three human cytochrome p450 2E1 variants with amino acid substitutions. Xenobiotica 33:575-586.
40. Hasumura, Y., Teschke, R., and Lieber, C. S. 1975. Acetaldehyde oxidation by hepatic mitochondria: decrease after chronic ethanol consumption. Science 189:727-729.
41. Hayashi, S., Watanabe, J., and Kawajiri, K. 1991. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 110:559-565.
42. Hildesheim A., Anderson, L., Chen, C., Cheng, Y., Brinton, L., Daly, A., Reed, C., Chen, I., Caporaso, N., Hsu, M., Chen, J., Idle, J., Hoover, R., Yang, C., and Chhabra, S. 1997. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. JNCI 89:1207-1212.
43. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., Karjalainen, A., and Vainio, H. 1993. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 14:85-88.
44. Hong, J., Pan, J., Gonzalez, F., Gelboin, H., and Yang, C. 1987. The induction of a specific form of cytochrome P450 (P450j) by fasting. Biochem. Biophys. Res. Commun. 142:1077-1083.
45. Howard, L. A., Micu, A. L., Sellers, E. M., and Tyndal, R. F. 2001. Low doses of ethanol and nicotine induce CYP2E1 and chlorzoxazone metabolism in rat liver. J. Pharmacol. Exp. Ther. 299:542-550.
46. Hu, Y., Oscarson, M., Johansson, I., Yue, Q., Dahl, M., Tabone, M., Arinco, S., Albano, E., and Ingelman-Sundberg, M. 1997. Genetic polymorphism of human CYP2E1: Characterization of two variant alleles. Mol. Pharmacol. 51:370-376. (Pubitemid 27118471)
47. Hu, Y., Hakkola, J., Oscarson, M., and Ingelman-Sundberg, M. 1999. Structural and functional characterization of the 5′-flanking region of the rat and human cytochrome P450 2E1 genes: Identification of a polymorphic repeat in the human gene. Biochem. Biophys. Res. Commun. 263:286-293.
48. Huang, Y. S., Chern, H. D., Su, W. J., Wu, J. C., Chang, S. C., Chiang, C. H., Chang, F. Y., and Lee, S. D. 2003. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology 37:924-930.
49. Hukkanen, J., Hakkola, J., Anttila, S., Piipari, R., Karjalainen, A., Pelkonen, O., and Raunio, H. 1997. Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450 s in human bronchoalveolar macrophages and peripheral blood lymphocytes. Mol. Carcinogen. 20:224-230.
50. Hung, H., Chuang, J., Chien, Y., Chern, H., Chiang, C., Hidesheim, A., and Chen, C. 1997. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1: Environmental factors and risk of oral cancer. Cancer Epidemiol. Biomarkers Prev. 6:901-905.
51. Ingleman-Sundberg, M., and Hagbjörk, A. 1982. On the significance of the cytochrome P-450-dependent hydroxyl radical mediated oxygenation mechanism. Xenobiotica 12:673-686.
52. Ingleman-Sundberg, M., and Johannson, I. 1984. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. J. Biol. Chem. 259:6447-6458.
53. Ingleman-Sundberg, M., Johannson, I., Yin, H., Terelius, Y., Eliasson, E., Clot, P., and Albano, E. 1993. Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 10:447-452.
54. Inoue, K., Yamazaki, H., and Shimada, T. 2000. Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene. Arch. Toxicol. 74:372-378.
55. Ishizaki, H., Brady, J., Ning, S., and Yang, C. 1990. Effect of phenethyl isothiocyanate on microsomal N-nitroxodimethylamine metabolism and other monooxygenase activities. Xenobiotica 20:255-264.
56. Iwahashi, K., Matsuo, Y., Suwaki, H., Nakamura, K., and Ichikawa, Y. 1995. CYP2E1 and ALDH2 genotype and alcohol dependence in Japanese. Alcohol Clin. Exp. Res. 19:564-566.
57. Iwahashi K., Ameno, S., Ameno, K., Okada., N., Kinoshita, H., Sakae, Y., Nakamura, K., Watanabe, M., Ijiri, I., and Harada, S. 1998. Relationship between alcoholism and CYP2E1 C/D polymorphism. Neuropsychobiology 38:218-221.
58. Johansson, I., and Ingelman-Sundberg, M. 1988. Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIEI) in rat and rabbit liver microsomes. Cancer Res. 48:5387-5390.
59. Johns, D. O., Daniell, W. E., Shen, D. D., Kalman, D. A., Dills, R. L., and Morgan, M. S. 2006. Ethanol-induced increase in the metabolic clearance of 1,1,1-trichloroethane in human volunteers. Toxicol. Sci. 92:61-70.
60. Joly, J., and Hetu, C. 1975. Effects of chronic ethanol administration in the rat. Relative dependency on dietary lipids. I. Induction of hepatic drug-metabolism enzymes in vitro. Biochem. Pharmacol. 24:1475-1480.
61. Joly, J., and Hetu, C. 1977. Effects of chronic ethanol administration in the rat. Relative dependency on dietary lipids. II. Paradoxical role of linoleate in the induction of hepatic drug metabolizing enzymes in vitro. Can. J. Physiol. Pharmacol. 55:34-41.
62. Kato, S., Shields, P., Caporaso, N., Hoover, R., Trump, B., Sugimura, H., Weston, A., and Harris, C. 1992. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res. 52:6712-6715.
63. Kato S., Shield, P. G., Caporaso, N. E., Sugimura, H., Trivers, G. E., Tucker, M. A., Trump, B. F., Weston, A., and Harris, C. C. 2003. CYP2E1: Biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr. Mol. Med. 3:509-518.
64. Kessova, I., and Cederbaum, A. I. 1994. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epididemiol. Biomarkers Prev. 3:515-518.
65. Kedderis, G. L. 1997. Extrapolation of in vitro enzyme induction data to humans in vivo. Chem. Biol. Interact. 107:109-121.
66. Khani, S., Zaphiropoulos, P., Fujita, V., Porter, T., Koop, D., and Coon, M. 1987. cDNA and derived amino acid sequence of ethanolinducible rabbit liver cytochrome P-450 isozyme 3a (P-450ALC). Proc. Natl. Acad. Sci. USA 84:638-642.
67. Khemawoot, P., Nishino, K., Ishizaki, J., Yokogawa, K., and Miyamoto, K. 2007. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats. Eur. J. Pharmacol. 574:71-76. (Pubitemid 47503160)
68. Kim, S., and Novak, R. 1990. Induction of rat hepatic P-450IIEI (CYP 2E1) by pyridine: Evidence for a role of protein synthesis in the absence of transcriptional activation. Biochem. Biophys. Res. Commun. 166:1072-1079.
69. Kim, R., O'Shea, D., and Wilkinson, G. 1995. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to cyp2E1 genetic polymorphisms. Clin. Pharmacol. Ther. 57:645-666.
70. Kim, R., Yamazaki, H., Chiba, K., O'Shea, D., Mimura, M., Guengerich, P., Ishizaki, T., Shimada, T., and Wilkinson, G. 1996. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. Pharmacol. Exp. Ther. 279:4-11.
71. Kim, J., Lee, C., Park, Y., Kim, K., Kim, I., Sohn, Y., Min, H., Lee, J., and Namkoong, S. 2000. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1 and CYP2E1: Relation to the incidence rate of cervical carcinoma. Cancer 88:2082-2091.
72. Kiss, I., Sandor, J., Pajkos, G., Bogner, B., Hegedus, G., and Ember, I. 2000. Colorectal cancer risk in relation of genetic polymorphism of cytochrome P450 1A1, 2E1, and GSTM1 enzymes. Anticancer Res. 20:519-522.
73. Kirvisto, K., Linder, A., Friedel, G., Beaune, P., Belloc, C., Kroemer, H., and Fritz, P. 1995. Immunohistochemical localization of cytochrome P4502E1 in human pulmonary carcinoma and normal bronchial tissue. Virchows Arch. Toxicol. 426:243-247.
74. Kolm, R., Danielson, U., Zhang, Y., Talalay, P., and Mannervik, B. 1995. Isothiocyannates as substrates for human glutathione transferase: structure-activity studies. Biochem. J. 311:453-459.
75. Koop, D. 1992. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 6:724-730.
76. Koop, D., Crump, B., Nordblom, G., and Coon, M. 1985. Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: Ethanol, imidazole, trichloroethylene, acetone, pyrazole and isoniazid. Proc. Natl. Acad. Sci. USA 82:4065-4069.
77. Krishna, D., and Klotz, U. 1994. Extrahepatic metabolism of drugs in humans. Clin. Pharmacokinet. 26:144-160.
78. Kubota, S., Lasker, J., and Lieber, C. 1988. Molecular regulation of ethanol inducible cytochrome P-450-IIEI in hamsters. Biochem. Biophys. Res. Commun. 150:304-310.
79. Ladero, L., Agundez, J., Rodriguez-Lescure, A., Diaz-Rubio, M., and Benitez, J. 1996. RsaI polymorphism at the cytocrome P4502E1 locus and risk of hepatocellular carcinoma. Gut 39:330-333.
80. Lechevrel, M., Casson, A., Wolf, C., Hardie, L., Flinterman, M., Montesano, R., and Wild, C. 1999. Characterization of cytochrome P450 expression in human oesophageal mucosa. Carcinogenesis 20:243-248.
81. Leclercq, I., Desago, J., and Horsman,Y. 1998. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestions of watercress. Clin. Pharmacol. Ther. 64:144-149.
82. Lee, S., Buters, J., Pineau, T., Fernandez-Salguero, P., and Gonzalez, F. 1996. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 271:12063-12067.
83. Lee, A. M., Yue, J., and Tyndale, R. F. 2006. In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: Induction by chronic nicotine treatment. Drug Metab. Dispos. 34:1508-1515.
84. Le Marchand L., Sivaraman, Pierce, L., Seifried, A., Lum, A., Wilkens, L., and Lau, A. 1998. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res. 58:4858-4863.
85. Le Marchand, L., Wilkinson, G., and Wilkens, L. 1999. Genetic and dietary predictors of CYP2E1 activity: A phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol. Biomarkers Prev. 8:495-500.
86. Levin, W., Thomas, P., Oldfield, N., and Ryan, D. 1986. N-Demethylation of N-nitrosodimethylamine catalyzed by purified rat hepatic microsomal cytochrome P-450: Isozyme specificity and role of cytochrome b5. Arch. Biochem. Biophys. 248:158-165.
87. Li, D., Dandara, C., and Parker, M. I. 2005 Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the esophagus. Clin. Chem. Lab. Med. 43:370-375.
88. Lieber, C. 1994. Alcohol and the liver: 1994 update. Hepatology 106:1085-1105.
89. Lieber, C. 1997a. Ethanol metabolism, cirrhosis and alcoholism. Clin. Chim. Acta 257:59-84.
90. Lieber, C. 1997b. Cytochrome P-4502E1: Its physiological and pathological role. Physiol. Rev. 77:517-544.
91. Lin, D., Tang, Y., Peng, Q., Lu, S., Ambrosone, C., and Kadlubar, F. 1998. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P4502E1. Cancer Epidemiol. Biomarkers Prev. 7:1013-1018.
92. Lipscomb, J. C. 2003. How differences in enzyme expression can translate into pharmacokinetic variance and susceptibility to toxicity. J. Child. Health 1:189-202.
93. Lipscomb, J., and Kedderis, G. 2002. Incorporating human interindividual biotransformation variance in health risk assessment. Sci. Total Environ. 288:13-21.
94. Lipscomb, J. C., and Poet, T. S. 2008. In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacol. Ther. 118:82-103.
95. Lipscomb, J., Garrett, C., and Snawder, J. 1997. Cytochrome P450-dependent metabolism of trichloroethylene: Interindividual differences in humans. Toxicol. Appl. Pharmacol. 142:311-318.
96. Lipscomb, J. C., Teuschler, L. K., Swartout, J. C., Striley, C. A. F., and Snawder, J. E. 2003. Variance in microsomal protein content and cytochrome P450 2E1 and 3A forms in adult human liver. Toxicol. Mech. Methods 13:45-51.
97. Lucas, D., Berthou, F., Dreano, Y., Lozac'h, P., Volcent, A., and Menez, J. 1993. Comparison of levels of cytochromes P450, CYP1A2, CYP2E1 and their related monooxygenase activities in human surgical liver samples. Alcohol Clin. Exp. Res. 17:900-905.
98. Lucas, D., Gill, K., Menez, J., and Deitrich, R. 1995a. Differences in cytochrome P450 2E1 and 1A1 genotyping between American Indians and Caucasians. Alcohol Clin. Exp. Res. 19:74A.
99. Lucas, D., Menez, C., Girre, C., Berthou, F., Bodenez, P., Joannet, I., Hispard, E., Bardou, L., and Menez, J. 1995b. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 5:298-304.
100. Lucas, D., Menez, C., Girre, C., Bodenez, P., Hispard, E., and Menez, J. 1995c. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazaone hydroxylation in alcoholics during the withdrawal phase. Alcohol. Clin. Exp. Res. 19:362-366.
101. Lucas, D., Menez, J., and Berthou, F. 1996a. Chlorzoxazaone: An in vitro and in vivo substrate probe for liver CYP2E1. Methods Enzymol. 272:115-123.
102. Lucas, D., Menez, C., Floch, F., Gourlaouen, Y., Sparfel, O., Joannet, I., Bodenez, P., Jezequel, J., Gouerou, H., Berthou, F., Bardou, L., and Menez, J. 1996b. Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians. Alcohol. Clin. Exp. Res. 20:1033-1037.
103. Maezawa, Y., Yamauchi, M., and Toda, G. 1994. Association between restriction fragment length polymorphism of the human cytochrome p450IIE1 gene and susceptibility to alcoholic liver cirrhosis. Am. J. Gastroenterol. 89:561-565. (Pubitemid 24106224)
104. Martinez, C., Agundez, J., Olivera, M., LLerena, A., Ramirez, R., Hernandez, M., and Benitez, J. 1998. Influence of genetic admixture on polymorphisms of drug metabolizing enzymes: Analyses of mutations on NAT2 and Cyp2E1 genes in a mixed Hispanic population. Clin. Pharmacol. Ther. 63:623-628.
105. Matthias, C., Bockmuhl, U., Jahnke, V., Hones, P., Hayes, J., Alldersea, J., Gilford, J., Bailey, L., Bath, J., Worrall, S., Hand, P., Fryer, A., and Strange, R. 1998. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: Studies in upper aerodigestive tract cancers. Pharmacogenetics 8:91-100.
106. McBride, O. W., Umeno, M., Gelboin, H. V., and Gonzalez, F. J. 1987. A Taq I polymorphism in the human P450IIE1 gene on chromosome 10 (CYP2E). Nucleic Acids Res. 15:10071.
107. McCarver, D., Byun, R., Hines, R., Hichme, M., and Wegenek, W. A. 1998. Genetic polymorhism in the regulatory sequences of human Cyp2e1: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol. Appl. Pharmacol. 152:276-281.
108. Miller, K., and Yang, C. 1984. Studies on the mechanisms of induction of N-nitrosodimethylamine demethylase by fasting, acetone and ethanol. Arch. Biochem. Biophys. 229:483-491.
109. Mishin, V., Koivisto, T., and Lieber, C. 1996. The determination of cytochrome P-450 2E1 dependent p-nitrophenol hydroxylation by high performance liquid chromatography with electrochemical dectection. Anal. Biochem. 233:212-215.
110. Morgan, E. T., Koop, D. R., and Coon, M. J. 1983. Comparison of six rabbit cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen. Biochem. Biophys. Res. Commun. 112:8-13.
111. Morita, S., Yano, M., Shiozaki, H., Tsujinaka, T., Ebisui, C., Morimoto, T., Kishibuti, M., Fujita, J., Ogawa, A., Taniguchi, M., Inoue, M., Tamura, S., Yamazoki, K., Kikkawa, N., Mizunoya, S., and Monden, M. 1997. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous cell carcinoma of the esophagus. Int. J. Cancer 71:192-195.
112. Nakamura, K., Iwahashi, K., Matsuo, Y., Miyatake, R., and Ichikawa, Y. 1996. Characteristic of Japanese alcoholics with the atypical aldehydrogenase 2*2. I. A comparison of the genotypes of ALDH2, ADH2, ADH3 and cytochrome P4502E1 between alcoholics and non-alcoholics. Alcohol. Clin. Exp. Res. 20:52-55.
113. Nedelcheva, V., Gut, I., Soucek, P., Tichavska, B., Tynkova, L., Mraz, J., Guengerich, F., and Ingelman-Sundberg, M. 1999. Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression. Arch. Toxicol. 73:33-40.
114. Nelson, S. D. 1990. Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Dis. 10:267-278.
115. Ohnishi, K., and Lieber, S. 1977. Reconstitution of the microsomal ethanol oxidizing system (MEOS): Qualitative and quantitative changes of cytochrome P-450 after chronic ethanol consumption. J. Biol. Chem. 252:7124-7131.
116. Ono, S., Hatanaka, T., Hotta, H., Tsusui, M., Satoh, T., and Gonzalez, F. 1995. Chlorzoxazone is metabolized by human CYP1A2 as well as human CYP2E1. Pharmacogenetics 5:143-150.
117. O'Shea, D., Davis, S., Kim, R., and Wilkinson, G. 1994. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity. Clin. Pharmacol. Ther. 56:359-367.
118. Oyama T., Kawamoto, T., Mizoue, T., Sugio, K., Kodama, Y., Mitsudomi, T., and Yasumoto, K. 1997. Cytochrome P4502E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res. 17:583-588.
119. Pasanen, M., and Pelkonen, O. 1994. The expression and environmental regulation of P450 enzymes in human placenta. Crit. Rev. Toxicol. 24:211-229.
120. Perrot, N., Nalpas, B., Yang, C., and Beaune, P. 1989. Modulation of cytochrome P450 isozymes in human liver by ethanol and drug intake. Eur. J. Clin. Invest. 19:549-555.
121. Persson, I., Terelius, Y., and Ingelman-Sundberg, M. 1990. Cytochrome P-450-dependent formation of reactive oxygen radicals; Isozyme-specific inhibition of P-450 mediated reduction of oxygen and carbon tetrachloride Xenobiotica 20:887-900.
122. Persson I., Johansson, I., Bergling, H., Dahl, M., Seidegard, J., Rylander, R., Rannug, A., Hogberg, J., and Ingelman-Sundberg, M. 1993. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett. 319:207-211.
123. Peter, R., Bocker, R., Beaune, P., Iwasaki, M., Guengerich, F., and Yang, C. 1990. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIEI. Chem. Res. Toxicol. 3:566-573.
124. Peter, R., Bocker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C. S. 1991. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 3:566-573.
125. Pirmohamed, M., Quest, K., Kitteringham, N., Allott, R., Gilmore, I., and Park, B. 1994. Association between cytochrome P450 2E1 (CYP2E1) restriction fragment length polymorphism and alcoholic liver disease in Caucasians. Hepatology 20:317A.
126. Porter, T., Khani, S., and Coon, M. 1989. Induction and tissue specific expression of rabbit cytochrome P-450IIE1 and IIE2 genes. Mol. Pharmacol. 36:61-65.
127. Powell H., Kitteringham, N., Pirmohamed, M., Smith, D., and Park, B. 1998. Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype, and phenotype. Pharmacogenetics 8:411-421.
128. Raucy, J., Lasker, J., Kramer, J., Salazer, D., Lieer, C., and Corcoran, G. 1991. Induction of P-450IIE1 in the obese rat. Mol. Pharmacol. 39:275-280.
129. Raucy, J. L., Kraner, J. C., and Lasker, J. M. 1993. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23:1-20.
130. Reinke, L., Lai, E., and McCay, P. 1988. Ethanol feeding stimulates trichlormethyl radical formation from carbon tetrachloride in liver. Xenobiotica 18:1311-1318.
131. Rihs, H. P., Triebig, G., Werner, P., Rabstein, S., Heinze, E., Pesch, B., and Bruning, T. 2008. Association between genetic polymorphisms in styrene-metabolizing enzymes and biomarkers in styrene-exposed workers. J. Toxicol. Environ. Health A 71:866-873.
132. Ronis, M. J. J., Huang, J., Crouch, J., Mercado, C., Irby, D., Valentine, C. R., Lumpkin, C. K., Ingelman-Sundberg, M., and Badger, T. M. 1993. Cytochrome P450 2E1 induction during chronic ethanol exposure occurs by a two step mechanism associated with blood alcohol concentrations in rats. J. Pharmacol. Exp. Ther. 264:944-950. (Pubitemid 24283562)
133. Ryan, D. E., Ramanathan, L., Iida, S., Thomas, PE., Haniu, M., Shively, J. E., Lieber, C. S., and Levin, W. 1985. Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. J. Biol. Chem. 260:6385-6393.
134. Ryan, D., and Levin, W. 1990. Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther. 45:153-239.
135. Sakurai, K., and Cederbaum, A. 1998. Oxidative stress and cytotoxicity induced by ferric-nitrilotriacetate in HepG2 cells that express cytochrome P450 2E1. Mol. Pharmacol. 54:1024-1035.
136. Salazar, D., Sorge, C., and Corcoran, G. 1988. Obesity as a risk factor for drug-induced organ injury. VI. Increased hepatic P-450 concentration and microsomal ethanol oxidizing activity in the obese overfed rat. Biochem. Biophys. Res. Commun. 157:315-320. (Pubitemid 19004862)
137. Sai, Y., Yang, T., Krausz, K., Gonzalez, F., and Gelboin, H. 1999. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver. Pharmacogenetics 9:229-237.
138. Saito, K., Yamazoe,Y., Kamataki, T., and Kato R. 1983. Activation and detoxification of N-hydroxy-Tryp-P-2 by glutathione transferases. Carcinogenesis (Lond.) 4:1551-1557.
139. Sangrajrang S., Jedpiyawongse, A., and Srivatanakul, P. 2006. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population. Asian Pacific J. Cancer Prev. 7:415-419.
140. Sato, M., and Lieber, C. 1981. Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. J. Nutr. 111:2015-2023.
141. Schindler, J., Li, Y., Marion, M. J., Paroly, A., and Brandt-Rauf, P. W. 2007. The effect of genetic polymorphisms in the vinyl chloride metabolic pathway on mutagenic risk. J. Hum. Genet. 52:448-455.
142. Shi, S., Wang, Z., Smith, T., Hong, J., Chen, W., Ho, C., and Yang C. 1994. Effects of green tea and black tea on 4-(methynitrosamino)-1-(3-pyridyl)- 1-butanone bioactivation, DNA methylation and lung tumorigenesis I A/J mice. Cancer Res. 54:4641-4647.
143. Shields, P., Ambrosone, C., Graham, S., Bowman, E., Harrington, A., Gillenwater, K., Marshall, J., Vena, J., Laughlin, R., Nemoto, T., and Freudenheim, J. 1996. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer. Mol. Carcinogen. 17:144-150. (Pubitemid 26408189)
144. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:414-423.
145. Shimada, T., Tsumura, F., and Yamazaki, H. 1999. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metab. Dispos. 27:1274-1280.
146. Shows, T. B., McAlpine, P. J., Boucheix, C., Collins, F. S., Conneally, P. M., Frezal, J., Gershowitz, H., Goodfellow, P. N., Hall, J. G., Issitt, P., Jones, C. A., Knowles, B. B., Lewis, M., McKusick, V. A., Meisler, M., Morton, N. E., Rubenstein, P., Schanfield, M. S., Schmickel, R. D., Skolnick, M. H., Spence, M. A., Sutherland, G. R., Traver, M., Vancong, N., and Willard, H. F. 1987. Guidelines for human gene nomenclature. An international system for human gene nomenclature. Cytogenet. Cell Genet. l46:11-28.
147. Snyder, R., and Hedli, C. 1996. An overview of benzene metabolism. Environ. Health Perspect. 104(suppl. 6):1165-1171.
148. Song, B., Gelboin, H., Park, S., Yang, C., and Gonzalez, F. 1986. Complementary DNA and protein sequences of ethanol inducible rat and human cytochrome P-450s: Transcriptional and posttranscriptional regulation of the rat enzyme. J. Biol. Chem. 261:16689-16697.
149. Song, B., Matsunaga, T., Hardwick, J., Park, S., Veech, R., Yang, C.,
150. Song, B., Veech, R., Park, S., Gelboin, H., and Gonzalez, F. 1989. Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J. Biol. Chem. 264:3568-3572.
151. Song, B., Veech, R., and Saenger, P. 1990. Cytochrome P-450IIEI is elevated in lymphocytes from poorly controlled insulin dependent diabetics. J. Clin. Endocrinol. Metab. 71:1036-1040.
152. Stephens, E., Taylor, J., Kaplan, N., Yang, C., Hsieh, L., Lucier, G., and Bell, D. 1994. Ethnic variation in the CYP2E1 gene: Polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogentics 4:185-192.
153. Stubbins, M., and Wolf, C. 1999. Additional polymorphisms and cancer. In Metabolic polymorphisms and susceptibility to cancer, ed. W. Ryder, pp. 271-302. Lyon: International Agency for Research on Cancer. IARC Scientific Publication No. 148.
154. Sugimura, H., Hamada, G., Suzuki, I., Iwase, T., Kiyokawa, E., Kino, I., and Tsugane, S. 1995. CYP1A1 and CYP2E1 polymorphism and lung cancer, case control study in Rio de Janeiro, Brazil. Pharmacogenetics 5:S145-S148.
155. Takahashi, T., Lasker, J., Rosman, A., and Lieber, C. 1993. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 17:236-245.
156. Tanaka, E. 1998. In vivo age-related changes in hepatic drug-oxidizing capacity in humans. J. Clin. Pharmacol. Ther. 23:247-255.
157. Tan W., Song, N., Wang, G., Liu, Q., Tang, H., Kadlubar, F., and Lin, D. 2000. Impact of genetic polymorphisms in cytochrome P4502E1 and GST M1, T1, and P1 on susceptibility to esophageal cancer among high risk individuals in China. Cancer Epidemiol. Biomarkers Prev. 9:551-556.
158. Tassaneekyakul, W., Veronese, M., Birkett, D., Gonzalez, F., and Miners, J. 1993. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem. Pharmacol. 46:1975-1981.
159. Terelius, Y., Nersten-Hoog, C., Cronholm, T., and Ingerman-Sundberg, M. 1991. Acetaldehyde as a substrate for ethanol-inducible cytochrome P450 (CYP2E1). Biochem. Biophys. Res. Commun. 179:689-694.
160. Teschke, R., Moreno, F., and Petrides, A. 1981. Hepatic microsomal ethanol oxidizing system (MEOS): Respective roles of ethanol and carbohydrates for the enhanced activity after chronic alcohol consumption. Biochem. Pharmacol. 30:1745-1751.
161. Thomasson, H., Edenber, J., Crabb, D., Mai, X., Jerome, R., Li, T., Wang, S., Lin, Y., Lu, R., and Yin, S. 1991. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am. J. Hum. Genet. 48:677-681.
162. Togawa, H., Shinkai, S., and Mizutani, T. 2008. Induction of human UGT1A1 by bilirubin through AhR dependent pathway. Drug Metab. Lett. 2: 231-237.
163. Trichopoulos, D., Lagiou, P., Trichopoulou, A., and Trichopoulos, D. 2002. Nutritional epidemiology of cancer: accomplishments and prospects. Proc. Nutr. Soc. 61:217-222.
164. Tsutsumi, M., Lasker, J., Shimizi, M., Rosman, A., and Lieber, C. 1989. The intralobular distribution of ethanol-inducible P450 IIEI in rat and human liver. Hepatology 10:437-446.
165. Tsutsumi, M., Matsuda, Y., and Takada, A. 1993. Role of ethanol-inducible cytochrome P-450 2E1 in the development of hepatocellular carcinoma by the chemical carcinogen N-nitrosodemethylamine. Hepatology 18:1483-1489.
166. Tsutsumi, M., Takada, A., and Wang, J. 1994. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 107:1430-1435.
167. Uchimoto, T., Itoga, S., Nezu, M., Sunaga, M., Tomonaga, T., and Nomura, F. 2007. Role of the genetic polymorphisms in the 5′ flanking region for transcriptional regulation of the human CYP2E1 gene. Alcohol. Clin. Exp. Res. 31:36S-42S.
168. Uematsu F., Tsutsumi, M., Takase, S., Matsuda, Y., and Kawahara, H. 1991. Association between restriction fragment length polymorphism of the human cytochrome P4502E1 gene and susceptibility to lung cancer. Jpn. J. Cancer Res. 82:254-256.
169. Uematsu, F., Ikawa, S., Kikuchi, H., Sagami, I., Kanamaru, R., Abe, T., Satoh, K., Motomiya, M., and Watanabe, M. 1994. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIEI) gene and susceptibility to lung cancer: possible relation to low smoking exposure. Pharmacogenetics 4:58-63.
170. Ueshima Y., Tsutsumi, M., Takase, S., Matsuda, Y., and Yawahara, H. 1996. Acetaminophen metabolism in patients with different cytochrome P4502E1 genotypes. Alcohol. Clin. Exp. Res. 20:25A-28A.
171. Umbenhauer, D., Wild, C. P., Montesano, R., Saffhill, R., Boyle, J. M., Huh, N., Kirstein, U., Thomale, J., Rajewsky, M. F., and Lu, S. H. 1985. O(6)-Methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int. J. Cancer 36:661-665.
172. Vieira, I., Sonnier, M., and Crestiel, T. 1996. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem. 238:476-483.
173. Watanabe, J., Hayashi, S., Nakachi, K., Imai, K., Suda, Y., Sekine, T., and Kawajiri, K. 1990. PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res. 18:7194.
174. Watanabe, J., Hayashi, S., and Nakachi, K. 1994. Different regulation and expression of the human CYP2E1 gene due to Rsa I polymorphism in the 5′-flanking region. J. Biochem. 116:321-326.
175. Watanabe, J., Yang, JP., Eguchi, H., Hayashi, S., Imai, K., Nakachi, K., and Kawajiri, K. 1995. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn. J. Cancer Res. 86:245-248.
176. Wattenberg, L. 1992. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 52:2085s-2091s.
177. Wrighton, S., Thomas, P., Molowa, D., Haniu, M., Shively, J., Maines, S., Watkins, P., Parker, G., Mendez-Picon, G., Levin, W., and Guzelian, P. 1986. Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry 25:6731-6735.
178. Wu, D., Clejan, L., Potter, B., and Cederbaum, A. 1990. Rapid decrease of cytochrome P-450IIE1 in primary hepatocyte culture and its maintenance by added 4-methylpyrazole. Hepatocyte 6:1379-1389.
179. Wu, X., Shi, H., Jiang, H., Kemp, B., Hong, W. K., Delclos, G. L., and Spitz, M. R. 1997. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18:967-973.
180. Wu, X., Amos, C., Kemp, B., Shi, H., Jiang, H., Wan, Y., and Spitz, M. 1998. Cytochrome P4502E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol. Biomarkers.Prev. 7:13-18.
181. Yamazaki, H., Guo, Z., and Guengerich, FP. 1995. Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation. Drug Metab. Dispos. 23:438-440.
182. Yamazaki, H., Inoue, K., Mimura, M., Oda, Y., Guengerich, F., and Shimada, T. 1996. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Biochem. Pharmacol. 51:313-319.
183. Yamazaki, H., and Shimada, T. 2006. Cytochrome P450 reconstitution systems. Methods Mol. Biol. 320:61-71.
184. Yang, C., and Smith, T. 1996. Mechanisms of nitrosamine bioactivation and carcinogenesis. Adv. Exp. Med. Biol. 387:385-394.
185. Yang, C., Yoo, J., Ishizaki, H., and Hong, J. 1990. Cytochrome P-450IIEI: Roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab. Rev. 22:147-159.
186. Yang, T., Krausz, K., Sai, Y., Gonzalez, F., and Gelboin, H. 1999. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism. Drug Metab. Dispos. 27:102-109.
187. Yoo, J., Guengerich, F., and Yang, C. 1988. Metabolism of N-nitosodialkylamines by human liver microsomes. Cancer Res. 48:1499-1504.
188. Yu, M., Gladek-Yarborough, A., Chiamprasert, S., Santella, R., Liaw, Y., and Chen, C. 1995. Cytochrome P-450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109:1266-1273.
189. Yun, Y., Casazza, J., Sohn, D., Veech, R., and Song, B. 1992. Pretranslational activation of cytochrome P-450IIE1 during ketosis induced by a high fat diet. Mol. Pharmacol. 41:474-479.
190. Zand, R., Nelson, S., Slattery, J., Thummel, K., Kalhorn, T., Adams, S., and Wright, J. 1993. Inhibition and induction of cytochrome P-4502E1 catalyzed oxidation by isoniazid in humans. Clin. Pharmacol. Ther. 54:142-149.